Comparison of the analytical and clinical performance of three immunoassay platforms for plasma glial fibrillary acidic protein in Alzheimer's disease.

Wang, Yifei; Ma, Xiaoli; Zou, Yutong; Wang, Tianyi; Chu, Shanshan; Mao, Chenhui; Yu, Songlin; Gao, Jing; Qiu, Ling

doi:10.1515/cclm-2025-1694

Comparison of the analytical and clinical performance of three immunoassay platforms for plasma glial fibrillary acidic protein in Alzheimer's disease.

2026-04-02, Clinical chemistry and laboratory medicine (10.1515/cclm-2025-1694) (online)
Yifei Wang, Xiaoli Ma, Yutong Zou, Tianyi Wang, Shanshan Chu, Chenhui Mao, Songlin Yu, Jing Gao, and Ling Qiu (?)

This study aimed to compare the analytical and clinical performance of plasma glial fibrillary acidic protein (GFAP) across three immunoassay platforms.

This article has not yet been included in any curations.

Comments

There are no comments on this article yet.

You need to login or register to comment.

BioSothis

Comparison of the analytical and clinical performance of three immunoassay platforms for plasma glial fibrillary acidic protein in Alzheimer's disease.